The risk factors for cytomegalovirus reactivation following stem cell transplantation.

about

Disseminated cytomegalovirus infection complicating active treatment of systemic lupus erythematosus: an emerging problem.

P2860

Q40499757-D79F76EF-19B6-4793-A3E5-653D6B742DEC

P2860

The risk factors for cytomegalovirus reactivation following stem cell transplantation.

Item

http://www.wikidata.org/entity/Q38751030

description

2016 nî lūn-bûn

@nan

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

name

The risk factors for cytomegalovirus reactivation following stem cell transplantation.

@en

type

Item

label

The risk factors for cytomegalovirus reactivation following stem cell transplantation.

@en

prefLabel

The risk factors for cytomegalovirus reactivation following stem cell transplantation.

@en

P1476

The risk factors for cytomegalovirus reactivation following stem cell transplantation.

@en

P2093

Ardeshir Ghavamzadeh

http://www.w3.org/2001/XMLSchema#string

Asieh Ashouri

http://www.w3.org/2001/XMLSchema#string

Bahareh Valadkhani

http://www.w3.org/2001/XMLSchema#string

Kheirollah Gholami

http://www.w3.org/2001/XMLSchema#string

Molouk Hadjibabaie

http://www.w3.org/2001/XMLSchema#string

Mona Kargar

http://www.w3.org/2001/XMLSchema#string

P2860

Surveillance of active human cytomegalovirus infection in hematopoietic stem cell transplantation (HLA sibling identical donor): search for optimal cutoff value by real-time PCR.

Opportunistic infections after blood and marrow transplantation.

Mechanisms of human cytomegalovirus (HCMV) (re)activation and its impact on organ transplant patients.

Biobehavioral influences on recovery following hematopoietic stem cell transplantation.

Impact of pretransplant donor and recipient cytomegalovirus serostatus on outcome for multiple myeloma patients undergoing reduced intensity conditioning allogeneic stem cell transplantation.

Overview of the diagnosis of cytomegalovirus infection.

Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan.

Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease.

Low-dose valgancyclovir as cytomegalovirus reactivation prophylaxis in allogeneic haematopoietic stem cell transplantation.

Cytomegalovirus infections in allogeneic stem cell recipients after reduced-intensity or myeloablative conditioning assessed by quantitative PCR and pp65-antigenemia.

P304

63-69

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/2279-042X.176554

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26985438

http://www.w3.org/2001/XMLSchema#string

P932

4776549

http://www.w3.org/2001/XMLSchema#string

The risk factors for cytomegalovirus reactivation following stem cell transplantation.

about

P2860

P2860

The risk factors for cytomegalovirus reactivation following stem cell transplantation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932